[go: up one dir, main page]

PE20141723A1 - Metodo para monitoreo, diagnostico y/o pronostico de trastornos relacionados con hipoxia utilizando nfat5 - Google Patents

Metodo para monitoreo, diagnostico y/o pronostico de trastornos relacionados con hipoxia utilizando nfat5

Info

Publication number
PE20141723A1
PE20141723A1 PE2014000470A PE2014000470A PE20141723A1 PE 20141723 A1 PE20141723 A1 PE 20141723A1 PE 2014000470 A PE2014000470 A PE 2014000470A PE 2014000470 A PE2014000470 A PE 2014000470A PE 20141723 A1 PE20141723 A1 PE 20141723A1
Authority
PE
Peru
Prior art keywords
nfat5
monitoring
hypoxia
prognosing
diagnosing
Prior art date
Application number
PE2014000470A
Other languages
English (en)
Inventor
Munoz Carlos Ernesto Irarrazabal
Original Assignee
Univ Los Andes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48044247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20141723(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Los Andes filed Critical Univ Los Andes
Publication of PE20141723A1 publication Critical patent/PE20141723A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7038—Hypoxia

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UN METODO PARA EL MONITOREO, DIAGNOSTICO Y PRONOSTICO DE HIPOXIA RELACIONADO A TRANSTORNOS EN UN PACIENTE USANDO NFAT5, EN DONDE EL METODO COMPRENDE: a) PROPORCIONAR UNA MUESTRA DEL CUERPO, QUE ES SANGRE, ORINA, ENTRE OTROS; b) CONCENTRAR LOS FACTORES DE TRANSCRIPCION PRESENTES EN LA MUESTRA; Y c) DETECTAR Y CUANTIFICAR NFAT5 EN LA MUESTRA TRATADA.
PE2014000470A 2011-10-03 2012-10-03 Metodo para monitoreo, diagnostico y/o pronostico de trastornos relacionados con hipoxia utilizando nfat5 PE20141723A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161542446P 2011-10-03 2011-10-03

Publications (1)

Publication Number Publication Date
PE20141723A1 true PE20141723A1 (es) 2014-11-26

Family

ID=48044247

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2014000470A PE20141723A1 (es) 2011-10-03 2012-10-03 Metodo para monitoreo, diagnostico y/o pronostico de trastornos relacionados con hipoxia utilizando nfat5

Country Status (8)

Country Link
US (1) US9631237B2 (es)
EP (1) EP2764114A4 (es)
BR (1) BR112014007947A2 (es)
CL (1) CL2014000809A1 (es)
CO (1) CO7020868A2 (es)
HK (1) HK1200877A1 (es)
PE (1) PE20141723A1 (es)
WO (1) WO2013050950A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107109364A (zh) 2014-09-04 2017-08-29 约翰霍普金斯大学 缺氧与常氧交替条件下的骨髓浸润淋巴细胞的激活
US20220243281A1 (en) * 2019-05-28 2022-08-04 Case Western Reserve University Compositions and methods for preserving dna methylation
EP3904883A1 (en) * 2020-04-07 2021-11-03 Sciomics GmbH Prediction and early diagnosis of acute kidney injury
CA3180452A1 (en) 2020-05-27 2021-12-02 Sanford D. Markowitz Compositions and methods for preserving dna methylation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158010A0 (en) * 2003-09-18 2004-03-28 Hadasit Med Res Service Methods and kits for the detection of prion diseases
WO2006001981A2 (en) * 2004-06-02 2006-01-05 The Regents Of The University Of California Methods for treating disease by modulating an osmotic stress pathway
WO2007114449A1 (en) * 2006-03-28 2007-10-11 Oncorex, Inc. Low-glucose-inducible or low-glucose-and-hypoxia-inducible genes, proteins, and uses thereof
CA2670134A1 (en) * 2006-11-21 2008-08-28 Beth Israel Deaconess Medical Center Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications
DK2323638T3 (da) * 2008-07-18 2014-08-11 Hills Pet Nutrition Inc Sammensætninger og fremgangsmåder til behandling af osteoartritis
JP2010187469A (ja) 2009-02-12 2010-08-26 Hitachi Consumer Marketing Inc 消費エネルギー積算値管理警報システム
WO2011057172A1 (en) * 2009-11-06 2011-05-12 University Of Miami Podocyte specific assays and uses thereof

Also Published As

Publication number Publication date
BR112014007947A2 (pt) 2017-04-18
US9631237B2 (en) 2017-04-25
CO7020868A2 (es) 2014-08-11
WO2013050950A3 (en) 2013-06-13
US20140255947A1 (en) 2014-09-11
EP2764114A2 (en) 2014-08-13
CL2014000809A1 (es) 2014-11-28
EP2764114A4 (en) 2015-05-06
HK1200877A1 (en) 2015-08-14
WO2013050950A2 (en) 2013-04-11

Similar Documents

Publication Publication Date Title
MX342735B (es) Diagnostico acompañante para terapia con agente anti-hialuronano y metodos de uso del mismo.
MX356986B (es) Metodo para detectar aductos de nucleosomas.
MX382244B (es) Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
MX2014006904A (es) Método y sistema para determinar la regularidad asociada a los trastornos del ritmo biológico.
MX2013002084A (es) Biomarcadores y metodos de tratamiento.
MX2018008421A (es) Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias.
MX2010014228A (es) Metodos y productos de diagnostico del p/gf-1 acompañante.
MX362514B (es) Kits y ensayos de diagnostico para la deteccion del receptor 1 de folato.
ES2570632T3 (es) Procedimiento de determinación del inhibidor de elastasa de leucocito in vitro del cáncer colorrectal
CO6731117A2 (es) Metodos para diagnosticar y tratar desórdenes relacionados con la longitud axial del ojo
EA201590027A1 (ru) Способы детекции заболеваний или состояний
MX2013014153A (es) Biomarcadores paa terapia de inhibidor de hedgehog.
MX2013003077A (es) Diagnostico de cancer de mama.
MX361731B (es) Método para diagnosticar cáncer y kit de diagnóstico usando medición de actividad de células nk.
BR112014005947A2 (pt) sistema de monitoramento de uma cadeia de medida de um turborreator
MX360236B (es) Uso de marcadores en el diagnostico y tratamiento de cancer de prostata.
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
GB201201766D0 (en) Method
MX2017006075A (es) Biomarcadores para la progresion de enfermedades en melanoma.
AR087363A1 (es) Uso del anticuerpo i-3859 para la deteccion y diagnostico de los canceres
BR112014009223A8 (pt) método para o diagnóstico da doença de niemann-pick
PE20141723A1 (es) Metodo para monitoreo, diagnostico y/o pronostico de trastornos relacionados con hipoxia utilizando nfat5
MX2022014741A (es) Metodos para detectar bordetella.
BR112013031431A2 (pt) método para o diagnóstico da doença de gaucher
BR112015014232A2 (pt) lesão renal aguda

Legal Events

Date Code Title Description
FD Application declared void or lapsed